Notice of Correction to the Key Date Section in PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"
Notice Number:
NOT-DA-21-080

Key Dates

Release Date:

September 10, 2021

Related Announcements

PAR-21-320 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert potential applicants to a change in Key Dates and Application Types Allowed in, PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

The following sections of  PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)".

Currently Reads:

Part 1. Key Dates

Section II. Award Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

November 15, 2021

November 15, 2021

November 15, 2021

February 2022

January 2022

April 2022

March 15, 2022

March 15, 2022

March 15, 2022

June 2022

May 2022

July 2022

August 10, 2022

August 10, 2022

August 10, 2022

November 2022

October 2022

December 2022

November 15, 2022

November 15, 2022

November 15, 2022

February 2023

January 2023

April 2023

March 15, 2023

March 15, 2023

March 15, 2023

June 2023

May 2023

July 2023

August 10, 2023

August 10, 2023

August 10, 2023

November 2023

October 2023

December 2023

November 15, 2023

November 15, 2023

November 15, 2023

February 2024

January 2024

April 2024

March 15, 2024

March 15, 2024

March 15, 2024

June 2024

May 2024

July 2024

August 09, 2024

August 09, 2024

August 09, 2024

November 2024

October 2024

December 2024

Correct Dates: (shown in bold italic)

Part 1. Key Dates

Section II. Award Information

Key Dates

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

November 15, 2021

November 15, 2021

November 15, 2021

February 2022

May 2022

July 2022

March 15, 2022

March 15, 2022

March 15, 2022

June 2022

October 2022

December 2022

August 10, 2022

August 10, 2022

August 10, 2022

November 2022

January 2023

April 2023

November 15, 2022

November 15, 2022

November 15, 2022

February 2023

May 2023

July 2023

March 15, 2023

March 15, 2023

March 15, 2023

June 2023

October 2023

December 2023

August 10, 2023

August 10, 2023

August 10, 2023

November 2023

January 2024

April 2024

November 15, 2023

November 15, 2023

November 15, 2023

February 2024

May 2024

July 2024

March 15, 2024

March 15, 2024

March 15, 2024

June 2024

October 2024

December 2024

August 09, 2024

August 09, 2024

August 09, 2024

November 2024

January 2025

April 2025


All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Aria Davis Crump, Sc.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA)
Telephone:301-435-0881
Email: acrump@nida.nih.gov

Guifang Lao, Ph.D.
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6173
Email: aklinwm@mail.nih.gov

Yu (Woody) Lin, M.D., Ph.D.
Integrative Neuroscience Branch
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301 435-1318
Email: ylin1@nida.nih.gov

Beth Babecki, M.A.
Coordinator, Training Hub
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0899
Email: bbabecki@nida.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices